|By Business Wire||
|April 23, 2014 07:50 AM EDT||
Research and Markets (http://www.researchandmarkets.com/research/56gj5m/high_content) has announced the addition of the "High Content Screening Market - Global Forecasts to 2018: Instruments, Applications, Software & Services Analysis" report to their offering.
The global high content screening market is a technology-driven market and is marked by the Threat of Obsolescence,' wherein technologies as well as their adoption by end users changes very rapidly. Pharmaceutical and biotechnology companies as well as academic and government institutes are increasingly focusing on using high content screening as a powerful research tool in drug discovery.
The high content screening software market is the fastest-growing segment in the high content screening market. In high content screening, the accuracy of the results obtained depends on image analysis and data management software. In recent years, enhanced image analysis and data management solutions have been introduced, but there is scope for these solutions to be further improvised to provide improved results. Many of the key players in the high content screening instruments market are collaborating with software companies to offer products with better software. For instance, in November 2010, PerkinElmer collaborated with Glencoe Software, Inc. to integrate Columbus Scope, a cellular imaging software solution for microscopy. With the data sharing facility, Columbus Scope helps in data management in high content screening.
In the coming years, Asian countries are expected to witness a high growth. These regions offer an array of opportunities for growth and are expected to be the new revenue pockets for high content screening. This region offers a high growth potential as compared to mature markets such as the U.S. Growth in the Asian market is spurred by government support for the development of innovative screening technologies and rising demand for outsourcing of drug discovery services. For instance, in September 2013, Global Health Innovative Technology Fund (GHIT Fund), granted $5.7 million to six global partnerships to support the R&D activities of these partnerships in the area of various infectious diseases like tuberculosis, malaria, and Chagas disease. Such fundings are expected to boost the growth of the high content screening market.
Key Topics Covered:
- Executive Summary
- Market Overview
- Global High Content Screening Market, By Product Type
- Global High Content Screening Market, By Application
- Global High Content Screening End Users Market
- Geographic Analysis
- Competitive Landscape
- Company Profiles
- Becton, Dickinson And Company
- Cell Signaling Technology, Inc.
- Danaher Corporation
- Ge Healthcare (Subsidiary Of General Electric Company)
- Genedata Ag
- Merck Kgaa
- Perkinelmer, Inc.
- Thermo Fisher Scientific, Inc.
- Thorlabs, Inc.
- Yokogawa Electric Corporation
For more information visit http://www.researchandmarkets.com/research/56gj5m/high_content
Dec. 9, 2016 10:00 PM EST Reads: 282
Dec. 9, 2016 09:45 PM EST Reads: 2,002
Dec. 9, 2016 09:30 PM EST Reads: 1,279
Dec. 9, 2016 08:00 PM EST Reads: 1,017
Dec. 9, 2016 07:45 PM EST Reads: 716
Dec. 9, 2016 06:45 PM EST Reads: 5,145
Dec. 9, 2016 06:15 PM EST Reads: 1,765
Dec. 9, 2016 05:30 PM EST Reads: 2,370
Dec. 9, 2016 05:30 PM EST Reads: 483
Dec. 9, 2016 05:15 PM EST Reads: 1,891
Dec. 9, 2016 05:15 PM EST Reads: 1,471
Dec. 9, 2016 05:15 PM EST Reads: 412
Dec. 9, 2016 05:00 PM EST Reads: 2,075
Dec. 9, 2016 04:45 PM EST Reads: 1,869
Dec. 9, 2016 04:45 PM EST Reads: 1,315